Molecular mechanisms of lymphangiogenesis in development and cancer

International Journal of Developmental Biology

Volumn 55, Issue 4-5, 2011, Pages 483-494

  Albrecht, Imke ^a   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Angiogenesis; Cancer; Development; Lymphangiogenesis; Metastasis; Signaling

Indexed keywords

VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; CAPILLARY; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; DEVELOPMENTAL BIOLOGY; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HUMAN; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM; MATURATION; MOLECULAR MECHANICS; MORPHOLOGY; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC METASTASIS; LYMPHATIC SYSTEM; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 79961004610     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103226ia     Document Type: Article

References (135)

1. ABTAHIAN F, GUERRIERO A, SEBZDA E, LU MM, ZHOU R, MOCSAI A, MYERS EE, HUANG B, JACKSON DG, FERRARI VA, TYBULEWICZ V, LOWELL CA, LEPORE JJ, KORETZKY GA, KAHN ML (2003). Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 299: 247-251.
2. AL-RAWI MA, WATKINS G, MANSEL RE, JIANG WG (2005). The effects of interleukin-7 on the lymphangiogenic properties of human endothelial cells. Int J Oncol 27: 721-730.
3. ALDERS M, HOGAN BM, GJINI E, SALEHI F, AL-GAZALI L, HENNEKAM EA, HOLMBERG EE, MANNENS MM, MULDER MF, OFFERHAUS GJ, PRESCOTT TE, SCHROOR EJ, VERHEIJ JB, WITTE M, ZWIJNENBURG PJ, VIKKULA M, SCHULTE-MERKER S, HENNEKAM RC (2009). Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 41: 1272-1274.
4. AUGUSTIN HG, KOH GY, THURSTON G, ALITALO K (2009). Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 10: 165-177.
5. BALDWIN ME, HALFORD MM, ROUFAIL S, WILLIAMS RA, HIBBS ML, GRAIL D, KUBO H, STACKER SA, ACHEN MG (2005). Vascular endothelial growth factor D is dispensable for development of the lymphatic system. Mol Cell Biol 25: 2441-2449.
6. BALUK P, FUXE J, HASHIZUME H, ROMANO T, LASHNITS E, BUTZ S, VESTWEBER D, CORADA M, MOLENDINI C, DEJANA E, MCDONALD DM (2007). Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204: 2349-2362.
7. BANERJI S, NI J, WANG SX, CLASPER S, SU J, TAMMI R, JONES M, JACKSON DG (1999). LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144: 789-801.
8. BANZIGER-TOBLER NE, HALIN C, KAJIYA K, DETMAR M (2008). Growth hormone promotes lymphangiogenesis. Am J Pathol 173: 586-597.
9. BAZIGOU E, XIE S, CHEN C, WESTON A, MIURA N, SOROKIN L, ADAMS R, MURO AF, SHEPPARD D, MAKINEN T (2009). Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell 17: 175-186.
10. BJORNDAHL M, CAO R, NISSEN LJ, CLASPER S, JOHNSON LA, XUE Y, ZHOU Z, JACKSON D, HANSEN AJ, CAO Y (2005a). Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc Natl Acad Sci USA 102: 15593-15598.
11. BJORNDAHL MA, CAO R, BURTON JB, BRAKENHIELM E, RELIGA P, GALTER D, WU L, CAO Y (2005b). Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res 65: 9261-9268.
12. BREITENEDER-GELEFF S, SOLEIMAN A, KOWALSKI H, HORVAT R, AMANN G, KRIEHUBER E, DIEM K, WENINGER W, TSCHACHLER E, ALITALO K, KERJASCHKI D (1999). Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: podoplanin as a specific marker for lymphatic endothelium. Am J Pathol 154: 385-394.
13. BURTON JB, PRICEMAN SJ, SUNG JL, BRAKENHIELM E, AN DS, PYTOWSKI B, ALITALO K, WU L (2008). Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis. Cancer Res 68: 7828-7837.
14. BUTLER MG, ISOGAI S, WEINSTEIN BM (2009). Lymphatic development. Birth Defects Res C Embryo Today 87: 222-231.
15. BUTTLER K, EZAKI T, WILTING J (2008). Proliferating mesodermal cells in murine embryos exhibiting macrophage and lymphendothelial characteristics. BMC Dev Biol 8: 43.
16. BUTTLER K, KREYSING A, VON KAISENBERG CS, SCHWEIGERER L, GALE N, PAPOUTSI M, WILTING J (2006). Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Dev Dyn 235: 1554-1562.
17. BYZOVA TV, GOLDMAN CK, JANKAU J, CHEN J, CABRERA G, ACHEN MG, STACKER SA, CARNEVALE KA, SIEMIONOW M, DEITCHER SR, DICORLETO PE (2002). Adenovirus encoding vascular endothelial growth factor-D induces tissue-specific vascular patterns in vivo. Blood 99: 4434-4442.
18. CABIOGLU N, YAZICI MS, ARUN B, BROGLIO KR, HORTOBAGYI GN, PRICE JE, SAHIN A (2005). CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer. Clin Cancer Res 11: 5686-5693.
19. CAO R, BJORNDAHL MA, RELIGA P, CLASPER S, GARVIN S, GALTER D, MEISTER B, IKOMI F, TRITSARIS K, DISSING S, OHHASHI T, JACKSON DG, CAO Y (2004). PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6: 333-345.
20. CAUNT M, MAK J, LIANG WC, STAWICKI S, PAN Q, TONG RK, KOWALSKI J, HO C, RESLAN HB, ROSS J, BERRY L, KASMAN I, ZLOT C, CHENG Z, LE COUTER J, FILVAROFF EH, PLOWMAN G, PEALE F, FRENCH D, CARANO R, KOCH AW, WU Y, WATTS RJ, TESSIER-LAVIGNE M, BAGRI A (2008). Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell 13: 331-342.
21. CHANG LK, GARCIA-CARDENA G, FARNEBO F, FANNON M, CHEN EJ, BUTTERFIELD C, MOSES MA, MULLIGAN RC, FOLKMAN J, KAIPAINEN A (2004). Dose-dependent response of FGF-2 for lymphangiogenesis. Proc Natl Acad Sci USA 101: 11658-11663.
22. CLASPER S, ROYSTON D, BABAN D, CAO Y, EWERS S, BUTZ S, VESTWEBER D, JACKSON DG (2008). A novel gene expression profile in lymphatics associated with tumor growth and nodal metastasis. Cancer Res 68: 7293-7303.
23. CLAVIN NW, AVRAHAM T, FERNANDEZ J, DALUVOY SV, SOARES MA, CHAUDHRY A, MEHRARA BJ (2008). TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295: H2113-H2127.
24. COCHRAN AJ, HUANG RR, LEE J, ITAKURA E, LEONG SP, ESSNER R (2006). Tumour-induced immune modulation of sentinel lymph nodes. Nat Rev Immunol 6: 659-670.
25. CRNIC I, STRITTMATTER K, CAVALLARO U, KOPFSTEIN L, JUSSILA L, ALITALO K, CHRISTOFORI G (2004). Loss of neural cell adhesion molecule induces tumor metastasis by up-regulating lymphangiogenesis. Cancer Res 64: 8630-8638.
26. CZYZYK TA, NING Y, HSU MS, PENG B, MAINS RE, EIPPER BA, PINTAR JE (2005). Deletion of peptide amidation enzymatic activity leads to edema and embryonic lethality in the mouse. Dev Biol 287: 301-313.
27. D'AMICO G, KORHONEN EA, WALTARI M, SAHARINEN P, LAAKKONEN P, ALITALO K (2010). Loss of endothelial Tie1 receptor impairs lymphatic vessel development-brief report. Arterioscler Thromb Vasc Biol 30: 207-209.
28. DANUSSI C, SPESSOTTO P, PETRUCCO A, WASSERMANN B, SABATELLI P, MONTESI M, DOLIANA R, BRESSAN GM, COLOMBATTI A (2008). Emilin1 deficiency causes structural and functional defects of lymphatic vasculature. Mol Cell Biol 28: 4026-4039.
29. DELLINGER M, HUNTER R, BERNAS M, GALE N, YANCOPOULOS G, ERICKSON R, WITTE M (2008). Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319: 309-320.
30. DING Y, SHIMADA Y, MAEDA M, KAWABE A, KAGANOI J, KOMOTO I, HASHIMOTO Y, MIYAKE M, HASHIDA H, IMAMURA M (2003). Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 9: 3406-3412.
31. DUMONT DJ, JUSSILA L, TAIPALE J, LYMBOUSSAKI A, MUSTONEN T, PAJUSOLA K, BREITMAN M, ALITALO K (1998). Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282: 946-949.
32. ENHOLM B, KARPANEN T, JELTSCH M, KUBO H, STENBACK F, PREVO R, JACKSON DG, YLA-HERTTUALA S, ALITALO K (2001). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res 88: 623-629.
33. FANG J, DAGENAIS SL, ERICKSON RP, ARLT MF, GLYNN MW, GORSKI JL, SEAVER LH, GLOVER TW (2000). Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67: 1382-1388.
34. FISCHER C, JONCKX B, MAZZONE M, ZACCHIGNA S, LOGES S, PATTARINI L, CHORIANOPOULOS E, LIESENBORGHS L, KOCH M, DE MOL M, AUTIERO M, WYNS S, PLAISANCE S, MOONS L, VAN ROOIJEN N, GIACCA M, STASSEN JM, DEWERCHIN M, COLLEN D, CARMELIET P (2007). Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131: 463-475.
35. FRANCOIS M, CAPRINI A, HOSKING B, ORSENIGO F, WILHELM D, BROWNE C, PAAVONEN K, KARNEZIS T, SHAYAN R, DOWNES M, DAVIDSON T, TUTT D, CHEAH KS, STACKER SA, MUSCAT GE, ACHEN MG, DEJANA E KOOPMAN P (2008). Sox18 induces development of the lymphatic vasculature in mice. Nature 456: 643-647.
36. FRITZ-SIX KL, DUNWORTH WP, LI M, CARON KM (2008). Adrenomedullin signaling is necessary for murine lymphatic vascular development. J Clin Invest 118: 40-50.
37. GALE NW, PREVO R, ESPINOSA J, FERGUSON DJ, DOMINGUEZ MG, YANCOPOULOS GD, THURSTON G, JACKSON DG (2007). Normal lymphatic development and function in mice deficient for the lymphatic hyaluronan receptor LYVE-1. Mol Cell Biol 27: 595-604.
38. GALE NW, THURSTON G, HACKETT SF, RENARD R, WANG Q, MCCLAIN J, MARTIN C, WITTE C, WITTE MH, JACKSON D, SURI C, CAMPOCHIARO PA, WIEGAND SJ, YANCOPOULOS GD (2002). Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3: 411-423.
39. GROGER M, LOEWE R, HOLNTHONER W, EMBACHER R, PILLINGER M, HERRON GS, WOLFF K, PETZELBAUER P (2004). IL-3 induces expression of lymphatic markers Prox-1 and podoplanin in human endothelial cells. J Immunol 173: 7161-7169.
40. HARRELL MI, IRITANI BM, RUDDELL A (2007). Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am J Pathol 170: 774-786.
41. HE Y, KOZAKI K, KARPANEN T, KOSHIKAWA K, YLA-HERTTUALA S, TAKAHASHI T, ALITALO K (2002). Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. J Natl Cancer Inst 94: 819-825.
42. HE Y, RAJANTIE I, ILMONEN M, MAKINEN T, KARKKAINEN MJ, HAIKO P, SALVEN P, ALITALO K (2004). Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis. Cancer Res 64: 3737-3740.
43. HIRAKAWA S, BROWN LF, KODAMA S, PAAVONEN K, ALITALO K, DETMAR M (2007). VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109: 1010-1017.
44. HIRAKAWA S, DETMAR M, KERJASCHKI D, NAGAMATSU S, MATSUO K, TANEMURA A, KAMATA N, HIGASHIKAWA K, OKAZAKI H, KAMEDA K, NISHIDA-FUKUDA H, MORI H, HANAKAWA Y, SAYAMA K, SHIRAKATA Y, TOHYAMA M, TOKUMARU S, KATAYAMA I, HASHIMOTO K (2009). Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease. Am J Pathol 175: 2235-2248.
45. HIRAKAWA S, HONG YK, HARVEY N, SCHACHT V, MATSUDA K, LIBERMANN T, DETMAR M (2003). Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells. Am J Pathol 162: 575-586.
46. HIRAKAWA S, KODAMA S, KUNSTFELD R, KAJIYA K, BROWN LF, DETMAR M (2005). VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med 201: 1089-1099.
47. HIRASHIMA M, SANO K, MORISADA T, MURAKAMI K, ROSSANT J, SUDA T (2008). Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev Biol 316: 149-159.
48. HOGAN BM, BOS FL, BUSSMANN J, WITTE M, CHI NC, DUCKERS HJ, SCHULTE-MERKER S (2009). Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting. Nat Genet 41: 396-398.
49. HONG YK, FOREMAN K, SHIN JW, HIRAKAWA S, CURRY CL, SAGE DR, LIBERMANN T, DEZUBE BJ, FINGEROTH JD, DETMAR M (2004). Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma-associated herpesvirus. Nat Genet 36: 683-685.
50. HONG YK, HARVEY N, NOH YH, SCHACHT V, HIRAKAWA S, DETMAR M, OLIVER G (2002). Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225: 351-357.
51. HORIGUCHI A, ITO K, SUMITOMO M, KIMURA F, ASANO T, HAYAKAWA M (2008). Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 71: 928-932.
52. HOSHIDA T, ISAKA N, HAGENDOORN J, DI TOMASO E, CHEN YL, PYTOWSKI B, FUKUMURA D, PADERA TP, JAIN RK (2006). Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66: 8065-8075.
53. HUNTINGTON GS, MCCLURE CFW (1908). The anatomy and development of the jugular lymph sacs in the domestic cat (Felis domestica). Anat Rec 2: 1-18.
54. ICHISE H, ICHISE T, OHTANI O, YOSHIDA N (2009). Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice. Development 136: 191-195.
55. IRIGOYEN M, ANSO E, MARTINEZ E, GARAYOA M, MARTINEZ-IRUJO JJ, ROUZAUT A (2007). Hypoxia alters the adhesive properties of lymphatic endothelial cells. A transcriptional and functional study. Biochim Biophys Acta 1773: 880-890.
56. IRJALA H, ALANEN K, GRENMAN R, HEIKKILA P, JOENSUU H, JALKANEN S (2003). Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res 63: 4671-4676.
57. IRRTHUM A, KARKKAINEN MJ, DEVRIENDT K, ALITALO K, VIKKULA M (2000). Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67: 295-301.
58. ISSA A, LE TX, SHOUSHTARI AN, SHIELDS JD, SWARTZ MA (2009). Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 69: 349-357.
59. IWATA C, KANO MR, KOMURO A, OKA M, KIYONO K, JOHANSSON E, MORISHITA Y, YASHIRO M, HIRAKAWA K, KAMINISHI M, MIYAZONO K (2007). Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res 67: 10181-10189.
60. JELTSCH M, KAIPAINEN A, JOUKOV V, MENG X, LAKSO M, RAUVALA H, SWARTZ M, FUKUMURA D, JAIN RK, ALITALO K (1997). Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423-1425.
61. JIANG S, BAILEY AS, GOLDMAN DC, SWAIN JR, WONG MH, STREETER PR, FLEMING WH (2008). Hematopoietic stem cells contribute to lymphatic endothelium. PLoS One 3: e3812.
62. JIN D, HARADA K, OHNISHI S, YAMAHARA K, KANGAWA K, NAGAYA N (2008). Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema. Cardiovasc Res 80: 339-345.
63. KAIPAINEN A, KORHONEN J, MUSTONEN T, VAN HINSBERGH VW, FANG GH, DUMONT D, BREITMAN M, ALITALO K (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566-3570.
64. KAJIYA K, HIRAKAWA S, MA B, DRINNENBERG I, DETMAR M (2005). Hepatocyte growth factor promotes lymphatic vessel formation and function. EMBO J 24: 2885-2895.
65. KARKKAINEN MJ, HAIKO P, SAINIO K, PARTANEN J, TAIPALE J, PETROVA TV, JELTSCH M, JACKSON DG, TALIKKA M, RAUVALA H, BETSHOLTZ C, ALITALO K (2004). Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80.
66. KARKKAINEN M J, SAARISTO A, JUSSILA L, KARILA KA, LAWRENCE EC, PAJUSOLA K, BUELER H, EICHMANN A, KAUPPINEN R, KETTUNEN MI, YLA-HERTTUALA S, FINEGOLD DN, FERRELL RE, ALITALO K (2001). A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 98: 12677-12682.
67. KARPANEN T, EGEBLAD M, KARKKAINEN MJ, KUBO H, YLA-HERTTUALA S, JAATTELA M, ALITALO K (2001). Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res 61: 1786-1790.
68. KARPANEN T, HECKMAN CA, KESKITALO S, JELTSCH M, OLLILA H, NEUFELD G, TAMAGNONE L, ALITALO K (2006a). Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20: 1462-1472.
69. KARPANEN T, WIRZENIUS M, MAKINEN T, VEIKKOLA T, HAISMA HJ, ACHEN MG, STACKER SA, PYTOWSKI B, YLA-HERTTUALA S, ALITALO K (2006b). Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol 169. 708-718.
70. KERJASCHKI D, HUTTARY N, RAAB I, REGELE H, BOJARSKI-NAGY K, BARTEL G, KROBER SM, GREINIX H, ROSENMAIER A, KARLHOFER F, WICK N, MAZAL PR (2006). Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat Med 12: 230-234.
71. KOPFSTEIN L, VEIKKOLA T, DJONOV VG, BAERISWYL V, SCHOMBER T, STRITTMATTER K, STACKER SA, ACHEN MG, ALITALO K, CHRISTOFORI G (2007). Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Am J Pathol 170: 1348-1361.
72. KREN A, BAERISWYL V, LEHEMBRE F, WUNDERLIN C, STRITTMATTER K, ANTONIADIS H, FASSLER R, CAVALLARO U, CHRISTOFORI G (2007). Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function. EMBO J 26: 2832-2842.
73. KUBO H, CAO R, BRAKENHIELM E, MAKINEN T, CAO Y, ALITALO K (2002). Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc Natl Acad Sci USA 99: 8868-8873.
74. KUCHLER AM, GJINI E, PETERSON-MADURO J, CANCILLA B, WOLBURG H, SCHULTE-MERKER S (2006). Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol 16: 1244-1248.
75. LEE K, PARK DO J, CHOE G, KIM HH, KIM WH, LEE HS (2010). Increased intratumoral lymphatic vessel density correlates with lymph node metastasis in early gastric carcinoma. Ann Surg Oncol 17: 73-80.
76. LEE S, KANG J, YOO J, GANESAN SK, COOK SC, AGUILAR B, RAMU S, LEE J, HONG YK (2009). Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate. Blood 113: 1856-1859.
77. LI L, LIU B, LI X, YANG S, XIAO J, CHEN M, ZHANG Y, MA J (2009). Vascular endothelial growth factor D and intratumoral lymphatics as independent prognostic factors in epithelial ovarian carcinoma. Anat Rec (Hoboken) 292: 562-569.
78. LIN FJ, CHEN X, QIN J, HONG YK, TSAI MJ, TSAI SY (2010). Direct transcriptional regulation of neuropilin-2 by COUP-TFII modulates multiple steps in murine lymphatic vessel development. J Clin Invest 120: 1694-1707.
79. LOHELA M, BRY M, TAMMELA T, ALITALO K (2009). VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154-165.
80. LUONG MX, TAM J, LIN Q, HAGENDOORN J, MOORE KJ, PADERA TP, SEED B, FUKUMURA D, KUCHERLAPATI R, JAIN RK (2009). Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice. J Cell Physiol 219: 430-437.
81. MAKINEN T, ADAMS RH, BAILEY J, LU Q, ZIEMIECKI A, ALITALO K, KLEIN R, WILKINSON GA (2005). PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19: 397-410.
82. MANDRIOTA SJ, JUSSILA L, JELTSCH M, COMPAGNI A, BAETENS D, PREVO R, BANERJI S, HUARTE J, MONTESANO R, JACKSON DG, ORCI L, ALITALO K, CHRISTOFORI G, PEPPER MS (2001). Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20: 672-682.
83. MARTTILA-ICHIHARA F, TURJA R, MIILUNIEMI M, KARIKOSKI M, MAKSIMOW M, NIEMELA J, MARTINEZ-POMARES L, SALMI M, JALKANEN S (2008). Macrophage mannose receptor on lymphatics controls cell trafficking. Blood 112: 64-72.
84. MARUYAMA K, II M, CURSIEFEN C, JACKSON DG, KEINO H, TOMITA M, VAN ROOIJEN N, TAKENAKA H, D'AMORE PA, STEIN-STREILEIN J, LOSORDO DW, STREILEIN JW (2005). Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J Clin Invest 115: 2363-2372.
85. MASHINO K, SADANAGA N, YAMAGUCHI H, TANAKA F, OHTA M, SHIBUTA K, INOUE H, MORI M (2002). Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 62: 2937-2941.
86. MITEVA DO, RUTKOWSKI JM, DIXON JB, KILARSKI W, SHIELDS JD, SWARTZ MA (2010). Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 106: 920-931.
87. MORISADA T, OIKE Y, YAMADA Y, URANO T, AKAO M, KUBOTA Y, MAEKAWA H, KIMURA Y, OHMURA M, MIYAMOTO T, NOZAWA S, KOH GY, ALITALO K, SUDA T (2005). Angiopoietin-1 promotes LYVE-1-positive lymphatic vessel formation. Blood 105: 4649-4656.
88. MURO AF, CHAUHAN AK, GAJOVIC S, IACONCIG A, PORRO F, STANTA G, BARALLE FE (2003). Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 162: 149-160.
89. NAGY JA, VASILE E, FENG D, SUNDBERG C, BROWN LF, DETMAR MJ, LAWITTS JA, BENJAMIN L, TAN X, MANSEAU EJ, DVORAK AM, DVORAK HF (2002). Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 196: 1497-1506.
90. NAKATA B, FUKUNAGA S, NODA E, AMANO R, YAMADA N, HIRAKAWA K (2008). Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer. Oncology 74: 69-75.
91. NELSON GM, PADERA TP, GARKAVTSEV I, SHIODA T, JAIN RK (2007). Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells. Neoplasia 9: 1038-1045.
92. NIESSEN K, ZHANG G, RIDGWAY JB, CHEN H, YAN M (2010). ALK1 signaling regulates early postnatal lymphatic vessel development. Blood 115: 1654-1661.
93. NIGHTINGALE TD, FRAYNE ME, CLASPER S, BANERJI S, JACKSON DG (2009). A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium. J Biol Chem 284: 3935-3945.
94. NORRMEN C, IVANOV KI, CHENG J, ZANGGER N, DELORENZI M, JAQUET M, MIURA N, PUOLAKKAINEN P, HORSLEY V, HU J, AUGUSTIN HG, YLA-HERTTUALA S, ALITALO K, PETROVA TV (2009). FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 185: 439-457.
95. NY A, KOCH M, SCHNEIDER M, NEVEN E, TONG RT, MAITY S, FISCHER C, PLAISANCE S, LAMBRECHTS D, HELIGON C, TERCLAVERS S, CIESIOLKA M, KALIN R, MAN WY, SENN I, WYNS S, LUPU F, BRANDLI A, VLEMINCKX K, COLLEN D, DEWERCHIN M, CONWAY EM, MOONS L, JAIN RK, CARMELIET P (2005). A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat Med 11: 998-1004.
96. OKA M, IWATA C, SUZUKI HI, KIYONO K, MORISHITA Y, WATABE T, KOMURO A, KANO MR, MIYAZONO K (2008). Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis. Blood 111: 4571-4579.
97. PADERA TP, KADAMBI A, DI TOMASO E, CARREIRA CM, BROWN EB, BOUCHER Y, CHOI NC, MATHISEN D, WAIN J, MARK EJ, MUNN LL, JAIN RK (2002). Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886.
98. PETROVA TV, KARPANEN T, NORRMEN C, MELLOR R, TAMAKOSHI T, FINEGOLD D, FERRELL R, KERJASCHKI D, MORTIMER P, YLA-HERTTUALA S, MIURA N, ALITALO K (2004). Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10: 974-981.
99. PETROVA TV, MAKINEN T, MAKELA TP, SAARELA J, VIRTANEN I, FERRELL RE, FINEGOLD DN, KERJASCHKI D, YLA-HERTTUALA S, ALITALO K (2002). Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21: 4593-4599.
100. PODGRABINSKA S, BRAUN P, VELASCO P, KLOOS B, PEPPER MS, SKOBE M (2002). Molecular characterization of lymphatic endothelial cells. Proc Natl Acad Sci USA 99: 16069-16074.
101. PURI MC, ROSSANT J, ALITALO K, BERNSTEIN A, PARTANEN J (1995). The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 14: 5884-5891.
102. RELIGA P, CAO R, BJORNDAHL M, ZHOU Z, ZHU Z, CAO Y (2005). Presence of bone marrow-derived circulating progenitor endothelial cells in the newly formed lymphatic vessels. Blood 106: 4184-4190.
103. ROBERTS N, KLOOS B, CASSELLA M, PODGRABINSKA S, PERSAUD K, WU Y, PYTOWSKI B, SKOBE M (2006). Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2. Cancer Res 66: 2650-2657.
104. RUDDELL A, HARRELL MI, MINOSHIMA S, MARAVILLA KR, IRITANI BM, WHITE SW, PARTRIDGE SC (2008a). Dynamic contrast-enhanced magnetic resonance imaging of tumor-induced lymph flow. Neoplasia 10: 706-13, 1 p following 713.
105. RUDDELL A, KELLY-SPRATT KS, FURUYA M, PARGHI SS, KEMP CJ (2008b). p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Oncogene 27: 3145-3155.
106. SABIN FR (1902). On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1: 367-389.
107. SATO TN, TOZAWA Y, DEUTSCH U, WOLBURG-BUCHHOLZ K, FUJIWARA Y, GENDRON-MAGUIRE M, GRIDLEY T, WOLBURG H, RISAU W, QIN Y (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376: 70-74.
108. SCHIMANSKI CC, SCHWALD S, SIMIANTONAKI N, JAYASINGHE C, GONNER U, WILSBERG V, JUNGINGER T, BERGER MR, GALLE PR, MOEHLER M (2005). Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11: 1743-1750.
109. SCHOMBER T, ZUMSTEG A, STRITTMATTER K, CRNIC I, ANTONIADIS H, LITTLEWOOD-EVANS A, WOOD J, CHRISTOFORI G (2009). Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis. Mol Cancer Ther 8: 55-63.
110. SHIBATA MA, MORIMOTO J, SHIBATA E, OTSUKI Y (2008). Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model. Cancer Gene Ther 15: 776-786.
111. SHIELDS JD, EMMETT MS, DUNN DB, JOORY KD, SAGE LM, RIGBY H, MORTIMER PS, ORLANDO A, LEVICK JR, BATES DO (2007a). Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis. Oncogene 26: 2997-3005.
112. SHIELDS JD, FLEURY ME, YONG C, TOMEI AA, RANDOLPH GJ, SWARTZ MA (2007b). Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling. Cancer Cell 11: 526-538.
113. SHIMODA H, BERNAS MJ, WITTE MH, GALE NW, YANCOPOULOS GD, KATO S (2007). Abnormal recruitment of periendothelial cells to lymphatic capillaries in digestive organs of angiopoietin-2-deficient mice. Cell Tissue Res 328: 329-337.
114. SHIN JW, MIN M, LARRIEU-LAHARGUE F, CANRON X, KUNSTFELD R, NGUYEN L, HENDERSON JE, BIKFALVI A, DETMAR M, HONG YK (2006). Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis. Mol Biol Cell 17: 576-584.
115. SHRESTHA B, HASHIGUCHI T, ITO T, MIURA N, TAKENOUCHI K, OYAMA Y, KAWAHARA K, TANCHAROEN S, KI-I Y, ARIMURA N, YOSHINAGA N, NOMA S, SHRESTHA C, NITANDA T, KITAJIMA S, ARIMURA K, SATO M, SAKAMOTO T, MARUYAMA I (2010). B cell-derived vascular endothelial growth factor a promotes lymphangiogenesis and high endothelial venule expansion in lymph nodes. J Immunol 184: 4819-4826.
116. SKOBE M, HAWIGHORST T, JACKSON DG, PREVO R, JANES L, VELASCO P, RICCARDI L, ALITALO K, CLAFFEY K, DETMAR M (2001). Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7: 192-198.
117. SLEEMAN J, SCHMID A, THIELE W (2009). Tumor lymphatics. Semin Cancer Biol 19: 285-297.
118. STACKER SA, CAESAR C, BALDWIN ME, THORNTON GE, WILLIAMS RA, PREVO R, JACKSON DG, NISHIKAWA S, KUBO H, ACHEN MG (2001). VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 7: 186-191.
119. SU JL, YANG PC, SHIH JY, YANG CY, WEI LH, HSIEH CY, CHOU CH, JENG YM, WANG MY, CHANG KJ, HUNG MC, KUO ML (2006). The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. Cancer Cell 9: 209-223.
120. TAKANAMI I (2003). Overexpression of CCR7 mRNA in nonsmall cell lung cancer: correlation with lymph node metastasis. Int J Cancer 105: 186-189.
121. TAMMELA T, ALITALO K (2010). Lymphangiogenesis: Molecular mechanisms and future promise. Cell 140: 460-476.
122. TANIGUCHI K, KOHNO R, AYADA T, KATO R, ICHIYAMA K, MORISADA T, OIKE Y, YONEMITSU Y, MAEHARA Y, YOSHIMURA A (2007). Spreds are essential for embryonic lymphangiogenesis by regulating vascular endothelial growth factor receptor 3 signaling. Mol Cell Biol 27: 4541-4550.
123. UHRIN P, ZAUJEC J, BREUSS JM, OLCAYDU D, CHRENEK P, STOCKINGER H, FUERTBAUER E, MOSER M, HAIKO P, FASSLER R, ALITALO K, BINDER BR, KERJASCHKI D (2010). Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation. Blood 115: 3997-4005.
124. WICK N, SAHARINEN P, SAHARINEN J, GURNHOFER E, STEINER CW, RAAB I, STOKIC D, GIOVANOLI P, BUCHSBAUM S, BURCHARD A, THURNER S, ALITALO K, KERJASCHKI D (2007). Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro. Physiol Genomics 28: 179-192.
125. WIGLE JT, HARVEY N, DETMAR M, LAGUTINA I, GROSVELD G, GUNN MD, JACKSON DG, OLIVER G (2002). An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21: 1505-1513.
126. WIGLE JT, OLIVER G (1999). Prox1 function is required for the development of the murine lymphatic system. Cell 98: 769-778.
127. WILEY HE, GONZALEZ EB, MAKI W, WU MT, HWANG ST (2001). Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst 93: 1638-1643.
128. WILTING J, AREF Y, HUANG R, TOMAREV SI, SCHWEIGERER L, CHRIST B, VALASEK P, PAPOUTSI M (2006). Dual origin of avian lymphatics. Dev Biol 292: 165-173.
129. WU M, HAN L, SHI Y, XU G, WEI J, YOU L, CHEN Y, ZHU T, LI Q, LI S, MENG L, LU Y, ZHOU J, WANG S, MA D (2010). Development and characterization of a novel method for the analysis of gene expression patterns in lymphatic endothelial cells derived from primary breast tissues. J Cancer Res Clin Oncol 136: 863-872.
130. XU Y, YUAN L, MAK J, PARDANAUD L, CAUNT M, KASMAN I, LARRIVEE B, DEL TORO R, SUCHTING S, MEDVINSKY A, SILVA J, YANG J, THOMAS JL, KOCH AW, ALITALO K, EICHMANN A, BAGRI A (2010). Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Exp Med 207: 115-30, S1-7.
131. YAMAZAKI T, YOSHIMATSU Y, MORISHITA Y, MIYAZONO K, WATABE T (2009). COUP-TFII regulates the functions of Prox1 in lymphatic endothelial cells through direct interaction. Genes Cells 14: 425-434.
132. YANAI Y, FURUHATA T, KIMURA Y, YAMAGUCHI K, YASOSHIMA T, MITAKA T, MOCHIZUKI Y, HIRATA K (2001). Vascular endothelial growth factor C promotes human gastric carcinoma lymph node metastasis in mice. J Exp Clin Cancer Res 20: 419-428.
133. YANIV K, ISOGAI S, CASTRANOVA D, DYE L, HITOMI J, WEINSTEIN BM (2006). Live imaging of lymphatic development in the zebrafish. Nat Med 12: 711-716.
134. YUAN L, MOYON D, PARDANAUD L, BREANT C, KARKKAINEN MJ, ALITALO K, EICHMANN A (2002). Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development 129: 4797-4806.
135. ZUMSTEG A, BAERISWYL V, IMAIZUMI N, SCHWENDENER R, RUEGG C, CHRISTOFORI G (2009). Myeloid cells contribute to tumor lymphangiogenesis. PLoS One 4:e7067.